Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uveal Melanoma × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 15 Fallopian Tube Neoplasms 11 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

tebentafusp 2 pembrolizumab 2 Cyclophosphamide 2 ulixertinib 1 trametinib 1 omipalisib 1 fludarabine phosphate 1 Vorinostat 1 Valproic Acid 1 Sunitinib 1 Specimen Handling 1 Radiosurgery 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 LY2940680 1 Ipilimumab 1 Interleukin-13 1 Imatinib Mesylate 1 GSK2141795 1 Fluorodeoxyglucose F18 1 Epilim 1 Dacarbazine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡